NCT00146601 Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Status COMPLETED Phase PHASE2
NCT00146588 Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer Status COMPLETED Phase NA
NCT00146562 Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer Status COMPLETED Phase PHASE2
NCT00146549 Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00146536 Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy Status COMPLETED Phase N/A
NCT00144703 Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00144677 Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00142480 Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer Status COMPLETED Phase PHASE2
NCT00142467 Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00142428 Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00142181 Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT00142168 CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia Status TERMINATED Phase PHASE2
NCT00142155 Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia Status COMPLETED Phase NA
NCT00142116 Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT00140478 Mifepristone (RU-486) in Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00139269 Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1/PHASE2
NCT00139243 Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1/PHASE2
NCT00139230 Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2